Low LDL-C: Is It all Good News?

被引：0
作者：
Hartz, Jacob [1 ]
机构：
[1] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA
来源：
CURRENT ATHEROSCLEROSIS REPORTS | 2024年 / 26卷 / 12期
基金：
美国国家卫生研究院;
关键词：
Hypobetalipoproteinemia; Lipid-lowering therapy; Atherosclerotic cardiovascular disease; Adverse effects; LOW-DENSITY-LIPOPROTEIN; FAMILIAL COMBINED HYPOLIPIDEMIA; VERY-LOW LEVELS; STATIN THERAPY; HEMORRHAGIC STROKE; APO-B; TOO LOW; CHOLESTEROL; RISK; SAFETY;
D O I：
10.1007/s11883-024-01238-y
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Purpose of reviewThis review presents the risks and benefits of very low LDL cholesterol and the safety of using lipid-lowering therapy to achieve these levels.Recent findingsA growing body of literature suggests that lower LDL cholesterol levels are associated with a reduced risk of cardiovascular disease. Further, achieving these levels with pharmaceuticals is remarkably safe. Although statins may slightly increase the risk of diabetes mellitus and hemorrhagic stroke, the benefits outweigh the risks.SummaryWhile recommendations from professional societies are increasingly aggressive, additional risk reduction could be achieved by setting more even ambitious LDL cholesterol goals.
引用
收藏
页码：673 / 681
页数：9
相关论文
共 70 条
  • [1] Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia
    Ahmed, A
    Keeffe, EB
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (12) : 2598 - 2599
  • [2] A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
    Amarenco, P.
    Kim, J. S.
    Labreuche, J.
    Charles, H.
    Abtan, J.
    Bejot, Y.
    Cabrejo, L.
    Cha, J-K
    Ducrocq, G.
    Giroud, M.
    Guidoux, C.
    Hobeanu, C.
    Kim, Y. J.
    Lapergue, B.
    Lavallee, P. C.
    Lee, B-C
    Lee, K-B
    Leys, D.
    Mahagne, M-H
    Meseguer, E.
    Nighoghossian, N.
    Pico, F.
    Samson, Y.
    Sibon, I
    Steg, P. G.
    Sung, S-M
    Touboul, P. J.
    Touze, E.
    Varenne, O.
    Vicaut, E.
    Yelles, N.
    Bruckert, E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) : 9 - 19
  • [3] Amarenco P, 2006, NEW ENGL J MED, V355, P549
  • [4] Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]
  • [5] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
    Baigent, C.
    Blackwell, L.
    Emberson, J.
    Holland, L. E.
    Reith, C.
    Bhala, N.
    Peto, R.
    Barnes, E. H.
    Keech, A.
    Simes, J.
    Collins, R.
    [J]. LANCET, 2010, 376 (9753) : 1670 - 1681
  • [6] Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217
    Benn, Marianne
    Watts, Gerald F.
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge G.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (17) : 1384 - 1394
  • [7] Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Betrisey, Sylvain
    Haller, Moa Lina
    Efthimiou, Orestis
    Speierer, Alexandre
    Del Giovane, Cinzia
    Moutzouri, Elisavet
    Blum, Manuel R.
    Aujesky, Drahomir
    Rodondi, Nicolas
    Gencer, Baris
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [8] Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials
    Boekholdt, S. Matthijs
    Hovingh, G. Kees
    Mora, Samia
    Arsenault, Benoit J.
    Amarenco, Pierre
    Pedersen, Terje R.
    LaRosa, John C.
    Waters, David D.
    DeMicco, David A.
    Simes, R. John
    Keech, Antony C.
    Colquhoun, David
    Hitman, Graham A.
    Betteridge, John
    Clearfield, Michael B.
    Downs, John R.
    Colhoun, Helen M.
    Gotto, Antonio M., Jr.
    Ridker, Paul M.
    Grundy, Scott M.
    Kastelein, John J. P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (05) : 485 - 494
  • [9] Guidance for the diagnosis and treatment of hypolipidemia disorders
    Bredefeld, Cindy
    Hussain, M. Mahmood
    Averna, Maurizio
    Black, Dennis D.
    Brin, Mitchell F.
    Burnett, John R.
    Charriere, Sybil
    Cuerq, Charlotte
    Davidson, Nicholas O.
    Deckelbaum, Richard J.
    Goldberg, Ira J.
    Granot, Esther
    Hegele, Robert A.
    Ishibashi, Shun
    Karmally, Wahida
    Levy, Emile
    Moulin, Philippe
    Okazaki, Hiroaki
    Poinsot, Pierre
    Rader, Daniel J.
    Takahashi, Manabu
    Tarugi, Patrizia
    Traber, Maret G.
    Di Filippo, Mathilde
    Peretti, Noel
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (06) : 797 - 812
  • [10] Missense mutations in APOB within the βα1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia
    Burnett, John R.
    Zhong, Shumei
    Jiang, Zhenghui G.
    Hooper, Amanda J.
    Fisher, Eric A.
    McLeod, Roger S.
    Zhao, Yang
    Barrett, P. Hugh R.
    Hegele, Robert A.
    van Bockxmeer, Frank M.
    Zhang, Hongyu
    Vance, Dennis E.
    McKnight, C. James
    Yao, Zemin
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (33) : 24270 - 24283
1234567